These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17764117)

  • 1. Herpes oncolytic therapy of salivary gland carcinomas.
    Reid V; Yu Z; Schuman T; Li S; Singh P; Fong Y; Wong RJ
    Int J Cancer; 2008 Jan; 122(1):202-8. PubMed ID: 17764117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy.
    Jarnagin WR; Zager JS; Hezel M; Stanziale SF; Adusumilli PS; Gonen M; Ebright MI; Culliford A; Gusani NJ; Fong Y
    Cancer Gene Ther; 2006 Mar; 13(3):326-34. PubMed ID: 16138120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of aggressive thyroid cancer with an oncolytic herpes virus.
    Yu Z; Eisenberg DP; Singh B; Shah JP; Fong Y; Wong RJ
    Int J Cancer; 2004 Nov; 112(3):525-32. PubMed ID: 15382081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic vaccinia virus therapy of salivary gland carcinoma.
    Chernichenko N; Linkov G; Li P; Bakst RL; Chen CH; He S; Yu YA; Chen NG; Szalay AA; Fong Y; Wong RJ
    JAMA Otolaryngol Head Neck Surg; 2013 Feb; 139(2):173-82. PubMed ID: 23429949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium depletion enhances nectin-1 expression and herpes oncolytic therapy of squamous cell carcinoma.
    Yu Z; Li S; Huang YY; Fong Y; Wong RJ
    Cancer Gene Ther; 2007 Aug; 14(8):738-47. PubMed ID: 17525764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nectin-1 is a marker of thyroid cancer sensitivity to herpes oncolytic therapy.
    Huang YY; Yu Z; Lin SF; Li S; Fong Y; Wong RJ
    J Clin Endocrinol Metab; 2007 May; 92(5):1965-70. PubMed ID: 17327376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic herpes simplex virus treatment of metastatic breast cancer.
    Wang J; Hu P; Zeng M; Rabkin SD; Liu R
    Int J Oncol; 2012 Mar; 40(3):757-63. PubMed ID: 22108767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of squamous cell carcinoma lymph node metastases to herpes oncolytic therapy.
    Yu Z; Li S; Huang YY; Lin SF; Fong Y; Wong RJ
    Clin Cancer Res; 2008 Mar; 14(6):1897-904. PubMed ID: 18347193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant treatment of hepatic malignancy: an oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection.
    Jarnagin WR; Zager JS; Klimstra D; Delman KA; Malhotra S; Ebright M; Little S; DeRubertis B; Stanziale SF; Hezel M; Federoff H; Fong Y
    Cancer Gene Ther; 2003 Mar; 10(3):215-23. PubMed ID: 12637943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An armed oncolytic herpes simplex virus expressing thrombospondin-1 has an enhanced in vivo antitumor effect against human gastric cancer.
    Tsuji T; Nakamori M; Iwahashi M; Nakamura M; Ojima T; Iida T; Katsuda M; Hayata K; Ino Y; Todo T; Yamaue H
    Int J Cancer; 2013 Jan; 132(2):485-94. PubMed ID: 22729516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 12 secretion enhances antitumor efficacy of oncolytic herpes simplex viral therapy for colorectal cancer.
    Bennett JJ; Malhotra S; Wong RJ; Delman K; Zager J; St-Louis M; Johnson P; Fong Y
    Ann Surg; 2001 Jun; 233(6):819-26. PubMed ID: 11371740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma.
    Wong RJ; Patel SG; Kim S; DeMatteo RP; Malhotra S; Bennett JJ; St-Louis M; Shah JP; Johnson PA; Fong Y
    Hum Gene Ther; 2001 Feb; 12(3):253-65. PubMed ID: 11177562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis inhibition by an oncolytic herpes virus expressing interleukin 12.
    Wong RJ; Chan MK; Yu Z; Ghossein RA; Ngai I; Adusumilli PS; Stiles BM; Shah JP; Singh B; Fong Y
    Clin Cancer Res; 2004 Jul; 10(13):4509-16. PubMed ID: 15240543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers.
    Varghese S; Rabkin SD; Liu R; Nielsen PG; Ipe T; Martuza RL
    Cancer Gene Ther; 2006 Mar; 13(3):253-65. PubMed ID: 16179929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic therapy of spontaneous prostate cancer in transgenic mice with oncolytic herpes simplex viruses.
    Varghese S; Rabkin SD; Nielsen GP; MacGarvey U; Liu R; Martuza RL
    Cancer Res; 2007 Oct; 67(19):9371-9. PubMed ID: 17909046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominant-negative fibroblast growth factor receptor expression enhances antitumoral potency of oncolytic herpes simplex virus in neural tumors.
    Liu TC; Zhang T; Fukuhara H; Kuroda T; Todo T; Canron X; Bikfalvi A; Martuza RL; Kurtz A; Rabkin SD
    Clin Cancer Res; 2006 Nov; 12(22):6791-9. PubMed ID: 17121900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer.
    Lin SF; Gao SP; Price DL; Li S; Chou TC; Singh P; Huang YY; Fong Y; Wong RJ
    Clin Cancer Res; 2008 Mar; 14(5):1519-28. PubMed ID: 18316577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve-sparing therapy with oncolytic herpes virus for cancers with neural invasion.
    Gil Z; Rein A; Brader P; Li S; Shah JP; Fong Y; Wong RJ
    Clin Cancer Res; 2007 Nov; 13(21):6479-85. PubMed ID: 17975160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic herpes simplex virus vectors for the treatment of human breast cancer.
    Liu RB; Rabkin SD
    Chin Med J (Engl); 2005 Feb; 118(4):307-12. PubMed ID: 15740669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic recombinant herpes simplex virus for treatment of orthotopic liver tumors in nude mice.
    Chung YS; Miyatake S; Miyamoto A; Miyamoto Y; Dohi T; Tanigawa N
    Int J Oncol; 2006 Apr; 28(4):793-8. PubMed ID: 16525626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.